DENALI ADVISORS LLC

Position in NVS — Novartis AG

CIK 1142941 SAN DIEGO, CA

Position in NVS

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$2,082,338

+$6,008 QoQ

Shares Held

13,287

-2.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#416

of 1,603 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 11% Shared 0% None 89%

Healthcare · as of Jun 30, 2026

DENALI ADVISORS LLC holds $21,250,231 across 5 Drug Manufacturers - General names. NVS ranks #2 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,917	$15,493,038
2	NVS	Novartis AG This page	13,287	$2,082,338
3	GSK	GSK plc	28,680	$1,503,405
4	AZN	Astrazeneca PLC	7,025	$1,332,080
5	JNJ	Johnson & Johnson	3,305	$839,370

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,082,338	13,287	-2.3%	Shares	Sole	2026-08-10
2026-03-31	$2,076,330	13,593	-0.0%	Shares	Sole	2026-05-08
2025-12-31	$1,874,756	13,598	+0.3%	Shares	Sole	2026-02-03
2025-09-30	$1,738,806	13,559	-37.8%	Shares	Sole	2025-11-07
2025-06-30	$2,639,591	21,813	-0.6%	Shares	Sole	2025-07-30
2025-03-31	$2,445,425	21,936	-0.8%	Shares	Sole	2025-05-05
2024-12-31	$2,151,718	22,112	+1.9%	Shares	Sole	2025-02-04
2024-09-30	$2,495,358	21,695	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.